AMPHASTAR PHARMACEUTICALS IN (AMPH) Forecast, Price Target & Analyst Ratings

NASDAQ:AMPH • US03209R1032

Current stock price

20.45 USD
+0.21 (+1.04%)
At close:
20.45 USD
0 (0%)
After Hours:

Analyst forecast overview

View the latest analyst price targets, stock forecast, EPS estimates, revenue projections, revisions, full estimates, rating distribution and upgrades/downgrades for AMPHASTAR PHARMACEUTICALS IN (AMPH).

Forecast Snapshot

Consensus Price Target

Price Target
$29.58
+ 44.65% Upside
→ Price target details

Next Earnings Forecast

Earnings Estimate
Release Date
May 5, 2026
Period
Q1 / 2026
EPS Estimate
$0.74
Revenue Estimate
177.57M
→ Full earnings forecast details

ChartMill Buy Consensus

Rating
76.92%
Weighted Analyst Rating Score
→ Analyst Ratings details

Price Target Details & History

Consensus Price Target and Range

Mean target
$29.58
Upside
+ 44.65%
From current price of $20.45 to mean target of $29.58, Based on 13 analyst forecasts
Low
$25.25
Median
$30.60
High
$31.50

Price Target Revisions

1 Month
-8.14%
3 Months
-8.56%

Price Target Summary

13 Wall Street analysts provided a forecast for the next 12 months for AMPH. The average price target is 29.58 USD. This implies a price increase of 44.65% is expected in the next year compared to the current price of 20.45.
The average price target has been revised downward by 8.56% in the past 3 months.
→ Find peer stocks trading 30% below analyst price target

Analyst Ratings & History

Current Analyst Ratings

AMPH Current Analyst RatingAMPH Current Analyst Buy, Sell and Hold Ratings.Current Analyst Rating Strong Buy Buy Hold Sell Strong Sell 1 2 3 4

Analyst Ratings History

AMPH Historical Analyst RatingsAMPH Historical Analyst Buy, Sell and Hold Ratings and number of analysts.Historical Monthly Analyst Rating -19 -17 -15 -13 -11 -9 -7 -5 -3 -1 2 4 6 8 10

Analyst Ratings Consensus

ChartMill Buy Consensus
76.92%
AMPH was analyzed by 13 analysts. The buy percentage consensus is at 77. So analysts seem to be have mildly positive about AMPH.
In the previous month the buy percentage consensus was at a similar level.
AMPH was analyzed by 13 analysts, which should be a sufficient number of analysts to have a meaningful average consensus rating.
→ Find peer stocks with a buy consensus above 85%

Recent Upgrades & Downgrades

DateFirmActionFrom → To
2026-02-27NeedhamMaintains Buy -> Buy
2026-02-27Wells FargoMaintains Overweight -> Overweight
2025-12-09BarclaysInitiate Equal-Weight
2025-11-07NeedhamMaintains Buy -> Buy
2025-10-22NeedhamReiterate Buy -> Buy
2025-08-26B of A SecuritiesMaintains Neutral -> Neutral
2025-08-12NeedhamUpgrade Hold -> Buy
2025-08-08Piper SandlerMaintains Neutral -> Neutral
2025-05-12JP MorganDowngrade Overweight -> Neutral
2025-05-08Wells FargoMaintains Overweight -> Overweight
2025-04-10NeedhamReiterate Hold -> Hold
2025-03-21Piper SandlerMaintains Neutral -> Neutral
2025-02-04Piper SandlerDowngrade Overweight -> Neutral
2024-11-22Wells FargoInitiate Overweight
2024-08-08NeedhamReiterate Hold
2024-08-08Piper SandlerMaintains Overweight -> Overweight
2024-06-27Piper SandlerReiterate Overweight -> Overweight
2024-05-22NeedhamReiterate Hold
2024-05-09NeedhamReiterate Hold
2024-04-10NeedhamReiterate Hold
2024-03-05JP MorganInitiate Overweight
2023-11-17B of A SecuritiesInitiate Neutral
2023-07-25JefferiesReiterate Buy -> Buy
2023-05-17Wells FargoMaintains Equal-Weight -> Equal-Weight
2022-10-25Piper SandlerMaintains Overweight

Next Earnings Forecast Details

Next Earnings Details

Release Date
May 5, 2026
Period
Q1 / 2026
EPS Estimate
$0.74
Revenue Estimate
177.57M
Revenue Q2Q
4.13%
EPS Q2Q
-0.53%
Number of Analysts
9

Next Earnings Revisions

Revenue (1 Month)
0.47%
Revenue (3 Months)
3.01%
EPS (1 Month)
-9.17%
EPS (3 Months)
-8.96%

Next Earnings Summary

AMPH is expected to report earnings on 5/5/2026. The consensus EPS estimate for the next earnings is 0.74 USD and the consensus revenue estimate is 177.57M USD.
The next earnings revenue estimate has been revised upward by 3.01% in the past 3 months.
→ Find peers expecting at least 20% revenue growth next quarter

Full Analyst Estimates 2026 - 2033

Yearly Earnings Per Share (EPS), Revenue, EBIT, EBITDA and Operating Margin Analyst Estimates

2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 2033
Revenue
YoY % growth
AMPH revenue by date.AMPH revenue by date.
644.395M
29.14%		731.967M
13.59%		719.887M
-1.65%		771.65M
7.19%		808.4M
4.76%		837.18M
3.56%		898.62M
7.34%		923.1M
2.72%		946.56M
2.54%		971.04M
2.59%		987.36M
1.68%
EBITDA
YoY % growth
AMPH ebitda by date.AMPH ebitda by date.
237.722M
79.09%		258.386M
8.69%		197.098M
-23.72%		250.78M
27.24%		264.39M
5.43%		252.71M
-4.42%		N/AN/AN/AN/AN/A
EBIT
YoY % growth
AMPH ebit by date.AMPH ebit by date.
199.687M
85.76%		205.419M
2.87%		140.403M
-31.65%		205.23M
46.17%		215.99M
5.24%		225.44M
4.38%		150.96M
-33.04%		151.98M
0.68%		157.08M
3.36%		158.1M
0.65%		156.06M
-1.29%
Operating Margin
AMPH operating margin by date.AMPH operating margin by date.
30.99%28.06%19.50%26.60%26.72%26.93%16.80%16.46%16.59%16.28%15.81%
EPS
YoY % growth
AMPH eps by date.AMPH eps by date.
3.30
67.51%		3.86
16.97%		3.25
-15.80%		3.38
3.95%		3.58
6.07%		3.92
9.31%		3.08
-21.36%		3.06
-0.66%		3.07
0.33%		3.03
-1.33%		2.95
-2.69%

All data in USD

Quarterly Earnings Per Share (EPS), Revenue, EBIT and EBITDA Analyst Estimates

Q1 / 26 Q2 / 26 Q3 / 26 Q4 / 26 Q1 / 27 Q2 / 27 Q3 / 27 Q4 / 27
EPS
Q2Q % growth		0.74
-0.53%		0.81
-4.54%		0.95
2.15%		0.86
18.16%		0.79
7.39%		0.83
1.82%		0.90
-5.51%		0.91
5.24%
Revenue
Q2Q % growth		177.57M
4.13%		187.22M
7.34%		205.89M
7.32%		200.94M
9.74%		179.52M
1.10%		192.78M
2.97%		206.04M
0.07%		219.91M
9.44%
EBITDA
Q2Q % growth		79.025M
55.25%		83.462M
18.54%		92.351M
36.46%		2.239M
-97.57%		N/AN/AN/AN/A
EBIT
Q2Q % growth		44.829M
20.21%		48.481M
14.93%		56.055M
121.39%		51.855M
45.64%		47.43M
5.80%		52.734M
8.77%		58.14M
3.72%		62.526M
20.58%

All data in USD

Yearly Earnings Per Share (EPS) and Revenue Trends vs Historical Data

AMPH Yearly Revenue VS EstimatesAMPH Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2017 2019 2021 2023 2025 2027 2029 2031 2033 200M 400M 600M 800M
AMPH Yearly EPS VS EstimatesAMPH Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2017 2019 2021 2023 2025 2027 2029 2031 2033 0 1 2 3

Long Term Forward Growth Forecast Summary

Long Term EPS Growth (CAGR)

EPS Next 3 Year
6.42%
EPS Next 5 Year
-1.20%

Long Term Revenue Growth (CAGR)

Revenue Next 3 Year
4.13%
Revenue Next 5 Year
4.48%

Long Term EBIT Growth (CAGR)

EBIT Next 3 Year
3.07%
EBIT Next 5 Year
N/A
→ Find peers expecting at least 20% CAGR revenue growth over the next 3 years

AMPHASTAR PHARMACEUTICALS IN / AMPH Forecast FAQ

Can you provide the average price target for AMPHASTAR PHARMACEUTICALS IN stock?

13 analysts have analysed AMPH and the average price target is 29.58 USD. This implies a price increase of 44.65% is expected in the next year compared to the current price of 20.45.

What is the next earnings date for AMPH stock?

AMPHASTAR PHARMACEUTICALS IN (AMPH) will report earnings on 2026-05-05.

What are the consensus estimates for AMPH stock next earnings?

The consensus EPS estimate for the next earnings of AMPHASTAR PHARMACEUTICALS IN (AMPH) is 0.74 USD and the consensus revenue estimate is 177.57M USD.

How do analysts rate AMPHASTAR PHARMACEUTICALS IN (AMPH)?

The consensus rating for AMPHASTAR PHARMACEUTICALS IN (AMPH) is 76.9231 / 100 . This indicates that analysts generally have a positive outlook on the stock.